Inhibitors in young boys with haemophilia
- 30 September 2000
- journal article
- review article
- Published by Elsevier in Best Practice & Research Clinical Haematology
- Vol. 13 (3) , 457-468
- https://doi.org/10.1053/beha.2000.0088
Abstract
No abstract availableKeywords
This publication has 57 references indexed in Scilit:
- The German National Immune Tolerance Registry, 1997 UpdateVox Sanguinis, 1999
- Analysis of the North American Immune Tolerance Registry (NAITR) 1993–1997: Current Practice ImplicationsVox Sanguinis, 1999
- Pharmaco‐economic aspects of inhibitor treatmentEuropean Journal of Haematology, 1998
- Early treatment with recombinant factor VIIa results in greater efficacy with less productEuropean Journal of Haematology, 1998
- Factor IX Inhibitors and Anaphylaxis in Hemophilia BJournal of Pediatric Hematology/Oncology, 1997
- Experience With Recombinant Factor VIIA in an Infant Hemophiliac With Inhibitors to FVIILC Undergoing Emergency Central Line PlacementJournal of Pediatric Hematology/Oncology, 1993
- Induction of Immune Tolerance in Patients with Hemophilia A and InhibitorsJournal of Pediatric Hematology/Oncology, 1992
- Induction of Immune Tolerance in Patients with Hemophilia and Antibodies to Factor VIII by Combined Treatment with Intravenous IgG, Cyclophosphamide, and Factor VIIINew England Journal of Medicine, 1988
- Von Willebrand factor contaminating porcine factor VIII concentrate (Hyate: C) causes platelet aggregationBritish Journal of Haematology, 1986
- Gene deletions in patients with haemophilia B and anti-factor IX antibodiesNature, 1983